ENTX · Company research
Entera Bio Ltd. Ordinary Shares (ENTX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.51 | $135,713,814.08 | 124404814.08 | 19.2142857142857143 | — | 0.14410714285714285004 | — | 18.6779265180291770 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.